U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...

A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...

John Flavin, Portal Innovations CEO, joins 'Fast Money' to talk what we can expect to see from the J.P. Morgan Healthcare ...

Donald Trump and his advisers are about to launch a consequential battle against unhealthy food producers and the ...

New research shows kids with more positive experiences – from stable routines to enriching social activities – were ...

MONDAY, Jan. 13, 2025 (HealthDay News) -- Obesity at cancer diagnosis is associated with inferior survival among children ...

A population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to results of a retrospective study.The association between obesity and mortality ...

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to ...

There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...